These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28285918)

  • 1. Jesridonin in combination with paclitaxel demonstrates synergistic anti-tumor activity in human esophageal carcinoma cells.
    Wang C; Yang D; Jiang L; Wang S; Wang J; Zhou K; Shi X; Chang L; Liu Y; Ke Y; Liu H
    Bioorg Med Chem Lett; 2017 May; 27(9):2058-2062. PubMed ID: 28285918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells.
    Wang C; Guo L; Wang S; Wang J; Li Y; Dou Y; Wang R; Shi H; Ke Y; Liu H
    Int J Mol Med; 2017 Mar; 39(3):645-653. PubMed ID: 28204832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JD enhances the anti-tumour effects of low-dose paclitaxel on gastric cancer MKN45 cells both in vitro and in vivo.
    Wang C; Wang R; Zhou K; Wang S; Wang J; Shi H; Dou Y; Yang D; Chang L; Shi X; Liu Y; Xu X; Zhang X; Ke Y; Liu H
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):971-982. PubMed ID: 27620208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells.
    Wang C; Jiang L; Wang S; Shi H; Wang J; Wang R; Li Y; Dou Y; Liu Y; Hou G; Ke Y; Liu H
    PLoS One; 2015; 10(6):e0130284. PubMed ID: 26103161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-induced apoptosis is blocked by camptothecin in human breast and pancreatic cancer cells.
    Jeansonne DP; Koh GY; Zhang F; Kirk-Ballard H; Wolff L; Liu D; Eilertsen K; Liu Z
    Oncol Rep; 2011 May; 25(5):1473-80. PubMed ID: 21331447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of trichostatin A and paclitaxel on apoptosis and mitochondrial membrane potential of human endometrial carcinoma Ark2 cells].
    Yang YN; Wang Y; Wang XG; Jiang SJ
    Ai Zheng; 2008 Aug; 27(8):816-21. PubMed ID: 18710614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lapatinib in combination with paclitaxel plays synergistic antitumor effects on esophageal squamous cancer.
    Guo XF; Li SS; Zhu XF; Dou QH; Liu D
    Cancer Chemother Pharmacol; 2018 Sep; 82(3):383-394. PubMed ID: 29909520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of a paclitaxel‑resistant human esophageal carcinoma cell line.
    Wang C; Guo LB; Ma JY; Li YM; Liu HM
    Int J Oncol; 2013 Nov; 43(5):1607-17. PubMed ID: 24002547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines.
    Faried A; Faried LS; Kimura H; Sohda M; Nakajima M; Miyazaki T; Kato H; Kanuma T; Kuwano H
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):301-8. PubMed ID: 16028102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Anti-glioma Effects in Vitro and in Vivo of Enediyne Antibiotic Neocarzinostatin and Paclitaxel via Enhanced Growth Delay and Apoptosis-Induction.
    Tianqin G; Chunlei C; Jingjing W
    Biol Pharm Bull; 2016 Oct; 39(10):1623-1630. PubMed ID: 27431785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective synergistic anticancer effects of cisplatin and oridonin against human p53-mutant esophageal squamous carcinoma cells.
    Yang H; Wang J; Khan S; Zhang Y; Zhu K; Zhou E; Gong M; Liu B; Kan Q; Zhang Q
    Anticancer Drugs; 2022 Jan; 33(1):e444-e452. PubMed ID: 34520434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Bcl-2 family and P-glycoprotein reverses paclitaxel resistance in human esophageal carcinoma cell line.
    Shi X; Dou Y; Zhou K; Huo J; Yang T; Qin T; Liu W; Wang S; Yang D; Chang L; Wang C
    Biomed Pharmacother; 2017 Jun; 90():897-905. PubMed ID: 28441715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of stathmin 1 silencing by siRNA on sensitivity of esophageal cancer cells Eca-109 to paclitaxel.
    Zhu HW; Jiang D; Xie ZY; Zhou MH; Sun DY; Zhao YG
    Genet Mol Res; 2015 Dec; 14(4):18695-702. PubMed ID: 26782519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
    Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective anticancer activity of the novel steroidal dihydropyridine spirooxindoles against human esophageal EC109 cells.
    Shi X; Qin T; Liu W; Zhang X; Li L; Huo J; Zhou K; Yang D; Zhang Y; Wang C
    Biomed Pharmacother; 2017 Dec; 96():1186-1192. PubMed ID: 29196102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apoptotic effect of the combined treatment of engineered antibody with paclitaxel on BT474 cells].
    Yin HJ; Cheng LS; Duan JL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar; 23(3):260-3. PubMed ID: 17343796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
    Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
    Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells.
    Hu M; Liu Q; Song P; Zhan X; Luo M; Liu C; Yang D; Cai Y; Zhang F; Jiang F; Zhang Y; Tang M; Zuo G; Zhou L; Luo J; Shi Q; Weng Y
    Oncol Rep; 2013 Jan; 29(1):185-92. PubMed ID: 23128493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Licochalcone-A sensitizes human esophageal carcinoma cells to TRAIL-mediated apoptosis by proteasomal degradation of XIAP.
    Yang P; Tuo L; Wu Q; Cao X
    Hepatogastroenterology; 2014; 61(133):1229-34. PubMed ID: 25436288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.